Patents by Inventor Jean-Marc Paris
Jean-Marc Paris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9461608Abstract: A radio frequency filter (1) comprises an input impedance adaption section (2) and a tank capacitor section (3). Thereby, the capacity of the input impedance adaption section (2) does not comprise a fixed capacitor, it only comprises switchable capacitors. Further, the tank capacitor section (3) does not comprise a fixed capacitor as well it only comprises switchable capacitors. The capacity of the input impedance adaption section (2) can be tuned independent of the tank capacity, section capacity by means of switchable capacitors. Hence, bandwidth and frequency of the radio frequency filter can be modified independent of each other. The imput impendance adaption section (2) is connected in series between the input and output of the filter (1). The tank capacitor section (3) is shunt connected between the input-output series path of the filter (1) and ground.Type: GrantFiled: February 14, 2008Date of Patent: October 4, 2016Assignee: NXP B.V.Inventors: Frederic Mercier, Luca Lococo, Vincent Rambeau, Jean-Marc Paris
-
Patent number: 8729035Abstract: This invention concerns compounds with the formula: in which: R1?OH or NH2; OR2, OR3, OR4 and OR5 are alcohol, ether, ester, carbonate, carbamate, sulphonate or sulphamate groups; and if R5?H if R2?R3?R4, then R2, R3 and R4?H; if R2?H, then R3?H and R4?H; if R3?H, then R2?H and R4?H; if R4?H, then R2?H and R3?H; if R5?H if R2=H, then R3?H and R4?H; if R3?H, then R2?H and R4?H; if R4?H, then R2?H and R3?H, their use as antibiotic agents and the process for synthesizing them.Type: GrantFiled: January 22, 2009Date of Patent: May 20, 2014Assignee: Universite Joseph FourierInventors: Jean-Luc Decout, Isabelle Baussanne, Jerome Desire, Jean-Marc Paris
-
Publication number: 20120022054Abstract: The present invention concerns novel substituted aryl derivatives, their process of preparation and their use for inhibiting virus replication and for treating viral diseases or disorders such as HIV and/or HCV infection.Type: ApplicationFiled: December 10, 2009Publication date: January 26, 2012Applicant: LABORATOIRE BIODIMInventors: Richard Benarous, Sabine Barbey-Treve, Jean-Marc Paris, Sebastien Berrut, Clarisse Berlioz-Torrent, Stephane Emiliani
-
Publication number: 20100311680Abstract: This invention concerns compounds with the formula: in which: R1=OH or NH2; OR2, OR3, OR4 and OR5 are alcohol, ether, ester, carbonate, carbamate, sulphonate or sulphamate groups; and if R5=H if R2=R3=R4, then R2, R3 and R4?H; if R2=H, then R3?H and R4?H; if R3=H, then R2?H and R4?H; if R4=H, then R2?H and R3?H; if R5?H if R2=H, then R3?H and R4?H; if R3=H, then R2?H and R4?H; if R4=H, then R2?H and R3?H, their use as antibiotic agents and the process for synthesising them.Type: ApplicationFiled: January 22, 2009Publication date: December 9, 2010Applicant: Universite Joseph FourierInventors: Jean-Luc Decout, Isabelle Baussane, Jerome Desire, Jean-Marc Paris
-
Patent number: 6833382Abstract: Novel group B streptogramin-like compounds of general formula (I), and a method for preparing streptogramines by mutasynthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramins are disclosed. Novel nucleotide sequences involved in the biosynthesis of said precursors, and their uses, are also disclosed.Type: GrantFiled: November 15, 2001Date of Patent: December 21, 2004Assignee: Aventis Pharma S.A.Inventors: Véronique Blanc, Denis Thibaut, Nathalie Bamas-Jacques, Francis Blanche, Joël Crouzet, Jean-Claude Barriere, Laurent Debussche, Alain Famechon, Jean-Marc Paris, Gilles Dutruc-Rosset
-
Publication number: 20030124996Abstract: The invention relates to a tuner for converting a RF signal (110) into an IF output signal (202), said tuner comprising a mixer (111) for generating a first IF signal (201), processing means (114) for filtering said first IF signal (201) so as to generate said IF output signal (202).Type: ApplicationFiled: November 21, 2002Publication date: July 3, 2003Inventors: Sebastien Amiot, Jean-Marc Paris, Lakhdar Zaid
-
Publication number: 20020142947Abstract: Novel group B streptogramine-like compounds of general formula (I), and a method for preparing streptogramines by muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines, are disclosed. Novel nucleotide sequences involved in the biosynthesis of said precursors, and their uses, are also disclosed.Type: ApplicationFiled: November 15, 2001Publication date: October 3, 2002Applicant: Aventis Pharma, S.A.Inventors: Veronique Blanc, Denis Thibaut, Nathalie Bamas-Jacques, Francis Blanche, Joel Crouzet, Jean-Claude Barriere, Laurent Debussche, Alain Famechon, Jean-Marc Paris, Gilles Dutruc-Rosset
-
Patent number: 6384014Abstract: Purified form of streptogramines, characterised in that it contains at least one component from group B streptogramines of general formula (I), wherein R1 is Me or Et, R2 is H or OH, and R3 is substituted benzyl of general formula (III), such that 1) if R2 is H, R is NR4R5, wherein one of R4 and R5 is H or an Me radical and the other is Me, and R′ is Cl or Br, or R is (C3-5)alkenyl if R4 and R5 are Me, or 2) R is H and R′ is halogen, alkylamino or dialkylamino, an ether-oxide residue, alkylthio, (C1-3)alkyl or trihalogenomethyl, or R is halogen, (C2-4)alkylamino, (C2-4)dialkylamino or methyl ethyl amino, pyrrolidino alkenyl alkyl amino, dialkylamino, an alkyl cycloalkylmethyl amino radical or in ether-oxide residue, alkylthio, alkylthiomethyl, (C1-6)alkyl, aryl or trihalogenomethyl, and R′ is H, or R is halogen, amino, alkylamino or dialkylamino, an ether-oxide residue, an alkylthio radical, (C1-6)alkyl or trihalogenomethyl and R′ is halogen, alkylamino or dialkylamino, an ether-oxideType: GrantFiled: March 10, 2000Date of Patent: May 7, 2002Assignee: Aventis Pharma S.A.Inventors: Pascal Anger, Jean-Claude Barriere, Bertrand Bonnavaud, Patrick Lefevre, Jean-Marc Paris, Denis Thibaut
-
Patent number: 6352839Abstract: The invention provides a method for preparing streptogramins using genetically-modified microorganisms to influence the biosynthesis of at least one of the precursors of the group B streptogramins. Cultures of the genetically-modified microorganisms are supplemented with a least one precursor that is different from the streptogramin precursor whose biosynthesis is altered and the streptogramins produced are recovered.Type: GrantFiled: March 20, 1997Date of Patent: March 5, 2002Assignee: Aventis Pharma S.A.Inventors: Véronique Blanc, Denis Thibaut, Nathalie Bamas-Jacques, Francis Blanche, Joël Crouzet, Jean-Claude Barriere, Laurent Debussche, Alain Famechon, Jean-Marc Paris, Gilles Dutruc-Rosset
-
Patent number: 5786449Abstract: Streptogramine derivatives of general formula (I) below, wherein the radical R.sub.1 is a methyl or ethyl radical, the radical R.sub.2 is a bromine or chlorine atom, or is an alkenyl radical with 3 to 5 carbon atoms when R.sub.3 and R.sub.4 are methyl, and one of R.sub.3 and R.sub.4 is a hydrogen atom or a methyl radical and the other is a methyl radical are disclosed. The streptogramine derivatives of general formula (I) have particularly useful antibacterial properties, and may be used in combination with a pristinamycin II derivative.Type: GrantFiled: January 31, 1997Date of Patent: July 28, 1998Assignee: Rhone-Poulenc Rorer S.A.Inventors: Jean-Claude Barriere, Jean-Marc Paris, Gerard Puchault
-
Patent number: 5556861Abstract: This invention relates to a novel 1,8 benzo[b]naphythyridine derivative of general formula (I), ##STR1## wherein R is H or a hydroxy, amino or alkylamino radical optionally substituted by amino or hydroxy, or R is dialkylamino of which the alkyl portions may form, with the nitrogen atom, a 5- or 6-membered heterocyclic ring which optionally contains a further heteroatom chosen from nitrogen, oxygen or sulphur, or R is C.sub.3-6 cycloalkylamino or an alkanylamino, N-alkyl N-alkanylamino or aminoalkylphenylamino radical; R.sub.1 and R.sub.2, which are the same or different, are in positions 2 and 3 and represent H, alkyl, C.sub.2-4 alkenyl, phenyl, or substituted phenyl, or R.sub.1 and R.sub.2 are in position 2 and represent alkyl; R.sub.3 is H or alkyl, fluoroalkyl, carboxyalkyl, C.sub.3-6 cycloalkyl, fluorophenyl, difluorophenyl, alkyloxy or alkylamino; and R.sub.4 is H or F, wherein the C.sub.Type: GrantFiled: June 7, 1995Date of Patent: September 17, 1996Assignee: Laboratoire Roger BellonInventors: Eric Bacque, Michel Barreau, Jean-Francois Desconclois, Philippe Girard, Michel Kryvenko, Marc P. Lavergne, Jean-Marc Paris, Guy Picaut
-
Patent number: 5476954Abstract: A method for preparing taxane derivatives having general formula (I), novel derivatives thereby obtained and compositions containing same. In general formula (I), R is t.butoxy or phenyl, R.sub.1 is hydrogen or acetyl, and Ar is substituted phenyl or optionally substituted .alpha. or .beta.-naphthyl. These novel taxane derivatives are useful as antileukemic and antitumoral agents.Type: GrantFiled: May 21, 1993Date of Patent: December 19, 1995Assignee: Rhone-Poulenc Rorer S.A.Inventors: Jean-Dominique Bourzat, Alain Commercon, Jean-Marc Paris
-
Patent number: 5326782Abstract: Di-p-toluoyl tartrate, di-t-butylacetyl tartrate, di-butyryl tartrate and di-i-valeryl tartrate of (dialkylamino-2 alkyl)sulphonyl-26 pristinamycin II.sub.B having general formula (I) wherein Alk represents a straight or branched alkylene radical and R represents straight or branched alkyl radicals, said radicals having from 1 to 10 carbon atoms.Type: GrantFiled: January 4, 1993Date of Patent: July 5, 1994Assignee: Rhone-Poulenc Rorer S.A.Inventors: Jean-Claude Barriere, Jean-Pierre Corbet, Jean-Marc Paris, Xavier Radisson
-
Patent number: 5310900Abstract: A Streptogramine derivative of formula (I) is disclosed, wherein the symbol Y is a hydrogen atom, a methyl amino or dimethylamino radical, or a protected methylamino radical, and the symbol R represents a methyl or ethyl radical.Type: GrantFiled: January 4, 1993Date of Patent: May 10, 1994Assignee: Rhone-Poulenc Rorer S.A.Inventors: Jean-Claude Barriere, Marie-Christine Dubroueucq, Maurice Fleury, Martine Largeron, Jean-Marc Paris
-
Patent number: 5304642Abstract: This invention relates to a process for preparing synergistic derivatives of formula (I), in which Y is hydrogen or dimethylamino, from pristinamycin I.sub.A or from virginiamycin, via a Mannich base, followed by elimination of the amine introduced.Type: GrantFiled: July 2, 1992Date of Patent: April 19, 1994Assignee: Rhone Poulenc SanteInventors: Jean-Pierre Bastart, Jean-Marc Paris, Xavier Radisson
-
Patent number: 5017576Abstract: Quinoline derivatives of formula: ##STR1## in which either R.sub.1 denotes trifluoromethyl, R.sub.2 and R.sub.3 form, together with the nitrogen atom to which they are attached, morpholino and R.sub.4 denotes a 4-methylphenyl, 4-chlorophenyl, 2-, 3- or 4-fluorophenyl, 4-methoxyphenyl, 4-methyl-3-fluorophenyl, 2,4-difluorophenyl or 4-aminophenyl,or R.sub.1 denotes trifluoromethyl, R.sub.2 and R.sub.3 form, together with the nitrogen atom to which they are attached, thiomorpholino, or R.sub.2 denotes methyl and R.sub.3 denotes 2-methoxyethyl and R.sub.4 denotes 4-methylphenyl,or R.sub.1 denotes chlorine fluorine, or methoxy, R.sub.2 and R.sub.3 form, together with the nitrogen atom to which they are attached, morpholino, and R.sub.4 denotes 4-methylphenyl, are useful as anxiolytics, hypnotics, anticonvulsants and antiepileptics.Type: GrantFiled: September 11, 1989Date of Patent: May 21, 1991Assignee: Rhone-Poulenc SanteInventors: Marie-Christine Dubroeucq, Jean-Marc Paris, Christian Renault
-
Patent number: 4798827Abstract: The invention provides new synergistin derivatives of formula ##STR1## in which Y is hydrogen or dimethylamino and R is a 3- or 4-quinuclidinyl radical, the isomers thereof and their mixtures, and their salts, also the preparation thereof. These compounds may be made by reaction of the corresponding 5-methylene compounds with the appropriate mercaptoquinuclidine. The products of formula (I), optionally combined with pristinamycin II.sub.A or a derivative of pristinamycin II.sub.B of the formula ##STR2## are useful as antimicrobials.Type: GrantFiled: May 21, 1987Date of Patent: January 17, 1989Assignee: Rhone-Poulenc SanteInventors: Jean-Claude Barriere, Claude Cotrel, Jean-Marc Paris
-
Patent number: 4775753Abstract: Pristinamycin II.sub.Type: GrantFiled: July 7, 1987Date of Patent: October 4, 1988Assignee: Rhone-Poulenc SanteInventors: Jean-Claude Barriere, Jean-Pierre Bastart, Jean-Marc Paris
-
Patent number: 4755599Abstract: The invention provides compounds of formula: ##STR1## in which R=H, halogen, alkyl, alkyloxy, alkythio, NH.sub.2, alkylamino, dialkylamino or CF.sub.3, R.sub.3 =H or alkyl,either R.sub.4 and R.sub.5 =H and R.sub.1 and R.sub.2 =H or alkyl, optionally substituted by alkenyl (2 to 4 C) or alternatively R.sub.1 and R.sub.2 form together a saturated heterocyclic ring containing 4 to 7 ring members and optionally containing another heteroatom such as O, S or N optionally substituted by alkyl,or R.sub.4 =H, R.sub.1 =H or alkyl and R.sub.2 and R.sub.5 together form an alkylene (3 to 4 C) radical and(i) either A=alkyl or phenyl which is unsubstituted or substituted by one or two substituents chosen from halogen, alkyl, alkyloxy, alkylthio, NH.sub.2, alkylamino, dialkylamino, NO.sub.2 or CF.sub.3 or alternatively A=pyridyl, benzyl or cycloalkyl (3 to 6 C), Y=S, SO or SO.sub.2 or a radical: ##STR2## in which R.sub.6 =H or alkyl and R.sub.Type: GrantFiled: February 3, 1987Date of Patent: July 5, 1988Assignee: Rhone-Poulenc SanteInventors: Jean-Claude Barriere, Jean-Pierre Corbet, Claude Cotrel, Daniel Farge, Jean-Marc Paris
-
Patent number: 4686309Abstract: The invention provides compounds of formula: ##STR1## in which R=H, halogen, alkyl, alkyloxy, alkythio, NH.sub.2, alkylamino, dialkylamino or CF.sub.3, R.sub.3 =H or alkyl, either R.sub.4 and R.sub.5 =H and R.sub.1 and R.sub.2 =H or alkyl, optionally substituted by alkenyl (2 to 4 C) or alternatively R.sub.1 and R.sub.2 form together a saturated heterocyclic ring containing 4 to 7 ring members and optionally containing another heteroatom such as O, S or N optionally substituted by alkyl, or R.sub.4 =H, R.sub.1 =H or alkyl and R.sub.2 and R.sub.5 together form an alkylene (3 to 4 C) radical and (i) either A=alkyl or phenyl which is unsubstituted or substituted by one or two substituents chosen from halogen, alkyl, alkyloxy, alkylthio, NH.sub.2, alkylamino, dialkylamino, NO.sub.2 or CF.sub.3 or alternatively A=pyridyl, benzyl or cycloalkyl (3 to 6C), Y=S, SO or SO.sub.2 or a radical: ##STR2## in which R.sub.6 =H or alkyl and R.sub.Type: GrantFiled: February 15, 1985Date of Patent: August 11, 1987Assignee: Rhone-Poulenc SanteInventors: Jean-Claude Barriere, Jean-Pierre Corbet, Claude Cotrel, Daniel Farge, Jean-Marc Paris